Enzyme Inhibitor - Global Market Outlook (2016-2022)                             

February 2017 | 171 pages | ID: E7E8D2C8F88EN
Stratistics Market Research Consulting

Abstracts

According to Stratistics MRC, the Global Enzyme Inhibitors Market is expected to grow at a CAGR of 4.3% during the forecast period 2016-2022. There has been an exponential rise in the occurrence of various diseases. Enzyme inhibitors are used as diagnostic agents to detect various diseases thus fueling the growth of enzyme inhibitor market. Moreover, usage of these inhibitors in the manufacturing of pesticides and herbicides favours the market growth. However, the existence of strict regulations increases the cost as well as launch period of new drugs, thereby hampering the growth of the global market.

Developing nations of North America and Europe has high growth because of improved diagnosis rate for the diseases, accessibility of medical facility and presence of established infrastructure. Asia Pacific market is expected to flourish due to the existence of large patient pool, enhancing healthcare infrastructure in developing nations such as India, China, and South Korea.

Some of the key players in the market include Amgen, AstraZeneca, Bayer AG, Eli Lilly, Johnson & Johnson, Merck KGaA, Novartis AG, Pfizer, Ranbaxy Laboratories Ltd, Roche and Takeda Pharma.

Type of Enzyme Inhibitors Covered:

• Reversible
• Irreversible

End Users Covered:

• Agrochemical
• Pharmaceutical
• Biotechnology
• Food & Beverage
• Other End Users

Disease Indications Covered:

• Arthritis
• Cardiovascular Disease
• Chronic Obstructive Pulmonary Disorders
• Gastrointestinal Disorders
• Inflammatory Diseases
• Other Diseases

Applications Covered:

• Pesticide Synthesis
• Drug Development
• Diagnostic Agent
• Other Applications

Regions Covered:

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• Italy
• UK
• Spain
• Rest of Europe
• Asia Pacific
• Japan
• China
• India
• Australia
• New Zealand
• Rest of Asia Pacific
• Rest of the World
• Middle East
• Brazil
• Argentina
• South Africa
• Egypt

What our report offers:

• Market share assessments for the regional and country level segments
• Market share analysis of the top industry players
• Strategic recommendations for the new entrants
• Market forecasts for a minimum of 6 years of all the mentioned segments, sub segments and the regional markets
• Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
• Strategic recommendations in key business segments based on the market estimations
• Competitive landscaping mapping the key common trends
• Company profiling with detailed strategies, financials, and recent developments
• Supply chain trends mapping the latest technological advancements

Contents

1 EXECUTIVE SUMMARY

2 PREFACE

2.1 Abstract
2.2 Stake Holders
2.3 Research Scope
2.4 Research Methodology
  2.4.1 Data Mining
  2.4.2 Data Analysis
  2.4.3 Data Validation
  2.4.4 Research Approach
2.5 Research Sources
  2.5.1 Primary Research Sources
  2.5.2 Secondary Research Sources
  2.5.3 Assumptions

3 MARKET TREND ANALYSIS

3.1 Introduction
3.2 Drivers
3.3 Restraints
3.4 Opportunities
3.5 Threats
3.6 Application Analysis
3.7 End User Analysis
3.8 Emerging Markets
3.9 Futuristic Market Scenario

4 PORTERS FIVE FORCE ANALYSIS

4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry

5 GLOBAL ENZYME INHIBITORS MARKET, BY TYPE

5.1 Introduction
5.2 Reversible
5.3 Irreversible

6 GLOBAL ENZYME INHIBITORS MARKET, BY END USER

6.1 Introduction
6.2 Agrochemical
6.3 Pharmaceutical
6.4 Biotechnology
6.5 Food & Beverage
6.6 Other End Users

7 GLOBAL ENZYME INHIBITORS MARKET, BY DISEASE INDICATION

7.1 Introduction
7.2 Arthritis
7.3 Cardiovascular Disease
7.4 Chronic Obstructive Pulmonary Disorders
7.5 Gastrointestinal Disorders
7.6 Inflammatory Diseases
7.7 Other Diseases

8 GLOBAL ENZYME INHIBITORS MARKET, BY APPLICATION

8.1 Introduction
8.2 Pesticide Synthesis
8.3 Drug Development
8.4 Diagnostic Agent
8.5 Other Applications

9 GLOBAL ENZYME INHIBITORS MARKET, BY GEOGRAPHY

9.1 North America
  9.1.1 US
  9.1.2 Canada
  9.1.3 Mexico
9.2 Europe
  9.2.1 Germany
  9.2.2 France
  9.2.3 Italy
  9.2.4 UK
  9.2.5 Spain
  9.2.6 Rest of Europe
9.3 Asia Pacific
  9.3.1 Japan
  9.3.2 China
  9.3.3 India
  9.3.4 Australia
  9.3.5 New Zealand
  9.3.6 Rest of Asia Pacific
9.4 Rest of the World
  9.4.1 Middle East
  9.4.2 Brazil
  9.4.3 Argentina
  9.4.4 South Africa
  9.4.5 Egypt

10 KEY DEVELOPMENTS

10.1 Agreements, Partnerships, Collaborations and Joint Ventures
10.2 Acquisitions & Mergers
10.3 New Product Launch
10.4 Expansions
10.5 Other Key Strategies

11 COMPANY PROFILING

11.1 Amgen
11.2 AstraZeneca
11.3 Bayer AG
11.4 Eli Lilly
11.5 Johnson & Johnson
11.6 Merck KGaA
11.7 Novartis AG
11.8 Pfizer
11.9 Ranbaxy Laboratories Ltd
11.10 Roche
11.11 Takeda Pharma

List Of Tables

LIST OF TABLES

Table 1 Global Enzyme Inhibitors Market Outlook, By Region (2014-2022) ($MN)
Table 2 Global Enzyme Inhibitors Market Outlook, By Type (2014-2022) ($MN)
Table 3 Global Enzyme Inhibitors Market Outlook, By Reversible (2014-2022) ($MN)
Table 4 Global Enzyme Inhibitors Market Outlook, By Irreversible (2014-2022) ($MN)
Table 5 Global Enzyme Inhibitors Market Outlook, By End User (2014-2022) ($MN)
Table 6 Global Enzyme Inhibitors Market Outlook, By Agrochemical (2014-2022) ($MN)
Table 7 Global Enzyme Inhibitors Market Outlook, By Pharmaceutical (2014-2022) ($MN)
Table 8 Global Enzyme Inhibitors Market Outlook, By Biotechnology (2014-2022) ($MN)
Table 9 Global Enzyme Inhibitors Market Outlook, By Food & Beverage (2014-2022) ($MN)
Table 10 Global Enzyme Inhibitors Market Outlook, By Other End Users (2014-2022) ($MN)
Table 11 Global Enzyme Inhibitors Market Outlook, By Disease Indication (2014-2022) ($MN)
Table 12 Global Enzyme Inhibitors Market Outlook, By Arthritis (2014-2022) ($MN)
Table 13 Global Enzyme Inhibitors Market Outlook, By Cardiovascular Disease (2014-2022) ($MN)
Table 14 Global Enzyme Inhibitors Market Outlook, By Chronic Obstructive Pulmonary Disorders (2014-2022) ($MN)
Table 15 Global Enzyme Inhibitors Market Outlook, By Gastrointestinal Disorders (2014-2022) ($MN)
Table 16 Global Enzyme Inhibitors Market Outlook, By Inflammatory Diseases (2014-2022) ($MN)
Table 17 Global Enzyme Inhibitors Market Outlook, By Other Diseases (2014-2022) ($MN)
Table 18 Global Enzyme Inhibitors Market Outlook, By Application (2014-2022) ($MN)
Table 19 Global Enzyme Inhibitors Market Outlook, By Pesticide Synthesis (2014-2022) ($MN)
Table 20 Global Enzyme Inhibitors Market Outlook, By Drug Development (2014-2022) ($MN)
Table 21 Global Enzyme Inhibitors Market Outlook, By Diagnostic Agent (2014-2022) ($MN)
Table 22 Global Enzyme Inhibitors Market Outlook, By Other Applications (2014-2022) ($MN)
Table 23 North America Enzyme Inhibitors Market Outlook, By Country (2014-2022) ($MN)
Table 24 North America Enzyme Inhibitors Market Outlook, By Type (2014-2022) ($MN)
Table 25 North America Enzyme Inhibitors Market Outlook, By Reversible (2014-2022) ($MN)
Table 26 North America Enzyme Inhibitors Market Outlook, By Irreversible (2014-2022) ($MN)
Table 27 North America Enzyme Inhibitors Market Outlook, By End User (2014-2022) ($MN)
Table 28 North America Enzyme Inhibitors Market Outlook, By Agrochemical (2014-2022) ($MN)
Table 29 North America Enzyme Inhibitors Market Outlook, By Pharmaceutical (2014-2022) ($MN)
Table 30 North America Enzyme Inhibitors Market Outlook, By Biotechnology (2014-2022) ($MN)
Table 31 North America Enzyme Inhibitors Market Outlook, By Food & Beverage (2014-2022) ($MN)
Table 32 North America Enzyme Inhibitors Market Outlook, By Other End Users (2014-2022) ($MN)
Table 33 North America Enzyme Inhibitors Market Outlook, By Disease Indication (2014-2022) ($MN)
Table 34 North America Enzyme Inhibitors Market Outlook, By Arthritis (2014-2022) ($MN)
Table 35 North America Enzyme Inhibitors Market Outlook, By Cardiovascular Disease (2014-2022) ($MN)
Table 36 North America Enzyme Inhibitors Market Outlook, By Chronic Obstructive Pulmonary Disorders (2014-2022) ($MN)
Table 37 North America Enzyme Inhibitors Market Outlook, By Gastrointestinal Disorders (2014-2022) ($MN)
Table 38 North America Enzyme Inhibitors Market Outlook, By Inflammatory Diseases (2014-2022) ($MN)
Table 39 North America Enzyme Inhibitors Market Outlook, By Other Diseases (2014-2022) ($MN)
Table 40 North America Enzyme Inhibitors Market Outlook, By Application (2014-2022) ($MN)
Table 41 North America Enzyme Inhibitors Market Outlook, By Pesticide Synthesis (2014-2022) ($MN)
Table 42 North America Enzyme Inhibitors Market Outlook, By Drug Development (2014-2022) ($MN)
Table 43 North America Enzyme Inhibitors Market Outlook, By Diagnostic Agent (2014-2022) ($MN)
Table 44 North America Enzyme Inhibitors Market Outlook, By Other Applications (2014-2022) ($MN)
Table 45 Europe Enzyme Inhibitors Market Outlook, By Country (2014-2022) ($MN)
Table 46 Europe Enzyme Inhibitors Market Outlook, By Type (2014-2022) ($MN)
Table 47 Europe Enzyme Inhibitors Market Outlook, By Reversible (2014-2022) ($MN)
Table 48 Europe Enzyme Inhibitors Market Outlook, By Irreversible (2014-2022) ($MN)
Table 49 Europe Enzyme Inhibitors Market Outlook, By End User (2014-2022) ($MN)
Table 50 Europe Enzyme Inhibitors Market Outlook, By Agrochemical (2014-2022) ($MN)
Table 51 Europe Enzyme Inhibitors Market Outlook, By Pharmaceutical (2014-2022) ($MN)
Table 52 Europe Enzyme Inhibitors Market Outlook, By Biotechnology (2014-2022) ($MN)
Table 53 Europe Enzyme Inhibitors Market Outlook, By Food & Beverage (2014-2022) ($MN)
Table 54 Europe Enzyme Inhibitors Market Outlook, By Other End Users (2014-2022) ($MN)
Table 55 Europe Enzyme Inhibitors Market Outlook, By Disease Indication (2014-2022) ($MN)
Table 56 Europe Enzyme Inhibitors Market Outlook, By Arthritis (2014-2022) ($MN)
Table 57 Europe Enzyme Inhibitors Market Outlook, By Cardiovascular Disease (2014-2022) ($MN)
Table 58 Europe Enzyme Inhibitors Market Outlook, By Chronic Obstructive Pulmonary Disorders (2014-2022) ($MN)
Table 59 Europe Enzyme Inhibitors Market Outlook, By Gastrointestinal Disorders (2014-2022) ($MN)
Table 60 Europe Enzyme Inhibitors Market Outlook, By Inflammatory Diseases (2014-2022) ($MN)
Table 61 Europe Enzyme Inhibitors Market Outlook, By Other Diseases (2014-2022) ($MN)
Table 62 Europe Enzyme Inhibitors Market Outlook, By Application (2014-2022) ($MN)
Table 63 Europe Enzyme Inhibitors Market Outlook, By Pesticide Synthesis (2014-2022) ($MN)
Table 64 Europe Enzyme Inhibitors Market Outlook, By Drug Development (2014-2022) ($MN)
Table 65 Europe Enzyme Inhibitors Market Outlook, By Diagnostic Agent (2014-2022) ($MN)
Table 66 Europe Enzyme Inhibitors Market Outlook, By Other Applications (2014-2022) ($MN)
Table 67 Asia Pacific Enzyme Inhibitors Market Outlook, By Country (2014-2022) ($MN)
Table 68 Asia Pacific Enzyme Inhibitors Market Outlook, By Type (2014-2022) ($MN)
Table 69 Asia Pacific Enzyme Inhibitors Market Outlook, By Reversible (2014-2022) ($MN)
Table 70 Asia Pacific Enzyme Inhibitors Market Outlook, By Irreversible (2014-2022) ($MN)
Table 71 Asia Pacific Enzyme Inhibitors Market Outlook, By End User (2014-2022) ($MN)
Table 72 Asia Pacific Enzyme Inhibitors Market Outlook, By Agrochemical (2014-2022) ($MN)
Table 73 Asia Pacific Enzyme Inhibitors Market Outlook, By Pharmaceutical (2014-2022) ($MN)
Table 74 Asia Pacific Enzyme Inhibitors Market Outlook, By Biotechnology (2014-2022) ($MN)
Table 75 Asia Pacific Enzyme Inhibitors Market Outlook, By Food & Beverage (2014-2022) ($MN)
Table 76 Asia Pacific Enzyme Inhibitors Market Outlook, By Other End Users (2014-2022) ($MN)
Table 77 Asia Pacific Enzyme Inhibitors Market Outlook, By Disease Indication (2014-2022) ($MN)
Table 78 Asia Pacific Enzyme Inhibitors Market Outlook, By Arthritis (2014-2022) ($MN)
Table 79 Asia Pacific Enzyme Inhibitors Market Outlook, By Cardiovascular Disease (2014-2022) ($MN)
Table 80 Asia Pacific Enzyme Inhibitors Market Outlook, By Chronic Obstructive Pulmonary Disorders (2014-2022) ($MN)
Table 81 Asia Pacific Enzyme Inhibitors Market Outlook, By Gastrointestinal Disorders (2014-2022) ($MN)
Table 82 Asia Pacific Enzyme Inhibitors Market Outlook, By Inflammatory Diseases (2014-2022) ($MN)
Table 83 Asia Pacific Enzyme Inhibitors Market Outlook, By Other Diseases (2014-2022) ($MN)
Table 84 Asia Pacific Enzyme Inhibitors Market Outlook, By Application (2014-2022) ($MN)
Table 85 Asia Pacific Enzyme Inhibitors Market Outlook, By Pesticide Synthesis (2014-2022) ($MN)
Table 86 Asia Pacific Enzyme Inhibitors Market Outlook, By Drug Development (2014-2022) ($MN)
Table 87 Asia Pacific Enzyme Inhibitors Market Outlook, By Diagnostic Agent (2014-2022) ($MN)
Table 88 Asia Pacific Enzyme Inhibitors Market Outlook, By Other Applications (2014-2022) ($MN)
Table 89 RoW Enzyme Inhibitors Market Outlook, By Country (2014-2022) ($MN)
Table 90 RoW Enzyme Inhibitors Market Outlook, By Type (2014-2022) ($MN)
Table 91 RoW Enzyme Inhibitors Market Outlook, By Reversible (2014-2022) ($MN)
Table 92 RoW Enzyme Inhibitors Market Outlook, By Irreversible (2014-2022) ($MN)
Table 93 RoW Enzyme Inhibitors Market Outlook, By End User (2014-2022) ($MN)
Table 94 RoW Enzyme Inhibitors Market Outlook, By Agrochemical (2014-2022) ($MN)
Table 95 RoW Enzyme Inhibitors Market Outlook, By Pharmaceutical (2014-2022) ($MN)
Table 96 RoW Enzyme Inhibitors Market Outlook, By Biotechnology (2014-2022) ($MN)
Table 97 RoW Enzyme Inhibitors Market Outlook, By Food & Beverage (2014-2022) ($MN)
Table 98 RoW Enzyme Inhibitors Market Outlook, By Other End Users (2014-2022) ($MN)
Table 99 RoW Enzyme Inhibitors Market Outlook, By Disease Indication (2014-2022) ($MN)
Table 100 RoW Enzyme Inhibitors Market Outlook, By Arthritis (2014-2022) ($MN)
Table 101 RoW Enzyme Inhibitors Market Outlook, By Cardiovascular Disease (2014-2022) ($MN)
Table 102 RoW Enzyme Inhibitors Market Outlook, By Chronic Obstructive Pulmonary Disorders (2014-2022) ($MN)
Table 103 RoW Enzyme Inhibitors Market Outlook, By Gastrointestinal Disorders (2014-2022) ($MN)
Table 104 RoW Enzyme Inhibitors Market Outlook, By Inflammatory Diseases (2014-2022) ($MN)
Table 105 RoW Enzyme Inhibitors Market Outlook, By Other Diseases (2014-2022) ($MN)
Table 106 RoW Enzyme Inhibitors Market Outlook, By Application (2014-2022) ($MN)
Table 107 RoW Enzyme Inhibitors Market Outlook, By Pesticide Synthesis (2014-2022) ($MN)
Table 108 RoW Enzyme Inhibitors Market Outlook, By Drug Development (2014-2022) ($MN)
Table 109 RoW Enzyme Inhibitors Market Outlook, By Diagnostic Agent (2014-2022) ($MN)
Table 110 RoW Enzyme Inhibitors Market Outlook, By Other Applications (2014-2022) ($MN)